The Serum Institute of India which had paused the trials of Oxford-AstraZeneca vaccine has been allowed to restart them. The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to continue testing the Oxford-AstraZeneca vaccine after it had been suspended on September 11, following an unexplained neurological illness in one ...